{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T07:20:41Z","timestamp":1693639241422},"reference-count":34,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A plethora of genetic abnormalities has been described in B-cell lymphomas, some of which arise when physiologic mechanisms involved in the generation of immunologic diversity go awry. Several different lymphoma types, such as follicular lymphoma (FL), mantle cell lymphoma (MCL), and Burkitt lymphoma (BL), are associated with hallmark translocations that occur as a consequence of these errors (t(14;18)(q32;q21), t(11;14)(q13;q32), and t(8;14)(q24;q32), respectively); however, none of these associations is absolute and none is completely diagnostically specific or sensitive. The advantages and limitations of a variety of different testing strategies in the 2 most common lymphomas, FL and diffuse large B-cell lymphoma (DLBCL), are reviewed herein, including an evaluation of the role of PCR-based approaches, FISH, and more nascent genomic technologies. The use of immunophenotypic strategies that may potentially provide, albeit imperfectly, more user-friendly surrogates for underlying genetic aberrations and cell-of-origin designations derived from gene-expression profiling analyses are also discussed. Finally, a newly designated category of lymphoma with features intermediate between DLBCL and BL is appraised, highlighting the central role of genetic analysis in this diagnostic gray zone.<\/jats:p>","DOI":"10.1182\/asheducation-2011.1.330","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T20:33:13Z","timestamp":1323289993000},"page":"330-335","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas"],"prefix":"10.1182","volume":"2011","author":[{"given":"Adam","family":"Bagg","sequence":"first","affiliation":[{"name":"University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"5","key":"2019111717220088700_B1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAP.0b013e3181ec7466","article-title":"The basis and rational use of molecular genetic testing in mature B-cell lymphomas","volume":"17","author":"Roullet","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"2019111717220088700_B2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2559.2010.03700.x","article-title":"Molecular cytogenetics of lymphoma: where do we stand in 2010?","volume":"58","author":"Kluin","year":"2011","journal-title":"Histopathology"},{"issue":"5","key":"2019111717220088700_B3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2353\/jmoldx.2008.080061","article-title":"Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology","volume":"10","author":"Bagg","year":"2008","journal-title":"J Mol Diagn"},{"key":"2019111717220088700_B4","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Swerdlow","year":"2008"},{"issue":"4","key":"2019111717220088700_B5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ijc.23958","article-title":"Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals","volume":"124","author":"Sch\u00fcler","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"2019111717220088700_B6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1309\/NAFYB0XW0V3G2JD5","article-title":"Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node\/extranodal tissue biopsies","volume":"121","author":"Cook","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"2019111717220088700_B7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","article-title":"Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances","volume":"19","author":"Guo","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"2019111717220088700_B8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2009.81","article-title":"t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region","volume":"22","author":"Gu","year":"2009","journal-title":"Mod Pathol"},{"issue":"2","key":"2019111717220088700_B9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"7337","key":"2019111717220088700_B10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"issue":"5","key":"2019111717220088700_B11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07528.x","article-title":"BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations","volume":"144","author":"Masir","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111717220088700_B12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000478-200604000-00015","article-title":"Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas","volume":"30","author":"Streubel","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2019111717220088700_B13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/PAS.0b013e31802ee4ab","article-title":"Primary follicular lymphoma of the testis and epididymis in adults","volume":"31","author":"Bacon","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2019111717220088700_B14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5858\/133.1.142","article-title":"Pediatric follicular lymphoma: a rare clinicopathologic entity","volume":"133","author":"Agrawal","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2019111717220088700_B15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/modpathol.2009.106","article-title":"Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma","volume":"22","author":"Chiu","year":"2009","journal-title":"Mod Pathol"},{"issue":"5","key":"2019111717220088700_B16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111717220088700_B17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2353\/jmoldx.2007.070038","article-title":"Minor BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases","volume":"9","author":"Weinberg","year":"2007","journal-title":"J Mol Diagn"},{"issue":"5","key":"2019111717220088700_B18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.leukres.2007.09.010","article-title":"FISH is better than BIOMED-2 PCR to detect IgH\/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections","volume":"32","author":"Espinet","year":"2008","journal-title":"Leuk Res"},{"issue":"7","key":"2019111717220088700_B19","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1080\/10428190701377022","article-title":"Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: superior performance of the IGK assays compared to IGH for suboptimal specimens","volume":"48","author":"Halld\u00f3rsd\u00f3ttir","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2019111717220088700_B20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2559.2010.03708.x","article-title":"Impact of gene expression profiling in lymphoma diagnosis and prognosis","volume":"58","author":"Orsborne","year":"2011","journal-title":"Histopathology"},{"issue":"17","key":"2019111717220088700_B21","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Choi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111717220088700_B22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"29","author":"Meyer","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111717220088700_B23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","article-title":"Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma","volume":"208","author":"Muris","year":"2006","journal-title":"J Pathol"},{"issue":"2","key":"2019111717220088700_B24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jcp.2008.057257","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)","volume":"62","author":"de Jong","year":"2009","journal-title":"J Clin Pathol"},{"issue":"18","key":"2019111717220088700_B25","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","article-title":"Gene expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"117","author":"Guti\u00e9rrez-Garc\u00eda","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111717220088700_B26","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1182\/blood-2008-02-136374","article-title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"111","author":"Malumbres","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2019111717220088700_B27","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/1078-0432.CCR-10-2573","article-title":"Classification of diffuse large B cell lymphoma into germinal center and activated B cell subtypes using a nuclease protection assay on paraffin embedded tissues","volume":"17","author":"Rimsza","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"23","key":"2019111717220088700_B28","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1182\/blood-2010-03-276766","article-title":"Immunoblastic morphology but not the immunohistochemical GCB\/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL","volume":"116","author":"Ott","year":"2010","journal-title":"Blood"},{"issue":"14","key":"2019111717220088700_B29","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1200\/JCO.2010.32.8385","article-title":"The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective","volume":"1029","author":"Salaverria","year":"2011","journal-title":"J Clin Oncol"},{"issue":"23","key":"2019111717220088700_B30","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111717220088700_B31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/modpathol.2010.76","article-title":"Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas","volume":"23","author":"Seegmiller","year":"2010","journal-title":"Mod Pathol"},{"issue":"17","key":"2019111717220088700_B32","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"issue":"20","key":"2019111717220088700_B33","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"2019111717220088700_B34","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/330\/1493584\/bep00111000330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/330\/1493584\/bep00111000330.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T05:01:17Z","timestamp":1639890077000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2011\/1\/330\/96979\/B-Cells-Behaving-Badly-A-Better-Basis-to-Behold"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2011.1.330","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,10]]}}}